PHI with Coronary Artery Bypass Graft
How does this condition affect your private health insurance?
An aortocoronary vein bypass, commonly known as Coronary Artery Bypass Graft (CABG) surgery, is a major cardiac procedure addressing severe coronary artery disease. It involves rerouting blood flow around blocked or narrowed coronary arteries to restore adequate blood supply to the heart muscle. Typically, a healthy blood vessel, often a segment of the saphenous vein from the leg, is harvested and grafted from the aorta to a point past the blockage in the coronary artery. This creates a new path for oxygen-rich blood, alleviating symptoms like angina, improving heart function, and reducing the risk of heart attack, ultimately enhancing the patient's quality of life.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
The acute phase, including hospital stay and initial recovery, typically ranges from 1-2 weeks in the hospital followed by 6-12 weeks of significant recovery at home.
Duration of Illness (Lifetime)
The underlying coronary artery disease (CAD) is a chronic, lifelong condition. The bypass surgery provides significant symptomatic relief and improved prognosis, but regular monitoring, lifestyle modifications, and medication are required for life. Graft patency can diminish over 10-15 years, potentially requiring further interventions.
Cost of Treatment (Initial)
In Germany, a single bypass surgery (CABG) can range from 30,000 to 60,000 EUR, including hospital stay, surgery, and initial post-operative care. This figure can vary based on complexity and location.
Cost of Treatment (Lifetime)
Over a lifetime, costs include initial surgery, follow-up consultations, medications (e.g., antiplatelets, statins, beta-blockers), potential for cardiac rehabilitation (several thousand EUR), and possible future re-interventions (e.g., PCI or repeat CABG), which can total well over 100,000-200,000 EUR.
Mortality Rate
The in-hospital mortality rate for elective CABG in healthy individuals is generally low, around 1-3%. For high-risk patients or emergency cases, it can be significantly higher, up to 5-10% or more.
Risk of Secondary Damages
Moderate to high. Potential complications include stroke (1-2%), myocardial infarction (3-5%), kidney failure (2-5%), infection (1-3%), bleeding requiring re-operation (2-5%), arrhythmias (20-40% for atrial fibrillation), and cognitive dysfunction (short-term, up to 30-50%; long-term, 5-10%).
Probability of Full Recovery
High, but 'complete recovery' implies return to a state without any sequelae or need for ongoing management. While most patients achieve significant symptomatic relief and improved quality of life, the underlying CAD remains. Approximately 70-80% experience major symptom improvement and return to functional life, but lifelong medication and monitoring are essential.
Underlying Disease Risk
Very high. The primary underlying disease is severe Coronary Artery Disease (CAD). Patients typically have multiple cardiovascular risk factors and comorbidities, including hypertension (60-80%), dyslipidemia (70-90%), diabetes mellitus (30-50%), peripheral artery disease (10-20%), and chronic kidney disease (10-20%).